Two hundred tlfty pediatric «18 years of age) patients underwent orthotopic liver transplantation because of end-stage liver dIsease and were given combination therapy wllh cyclosporlne and prednisone. The most common Indications for transplantallon In decreasIng order of frequency were biliary atresia, Inborn errors of metabOlism, and postnecrotlc cirrhosis. The 5·year actuarial survival for the enllre group was 69.2%. Age and diagnosis did not Influence survival. Infections were the most common cause of death. followed by liver failure and cerebrovascular occident. The Impact of retraMplantation on survival depends on the Indication. The survival Is better when retransplan· tatlon Is carried out after re/ecllon than because of technical complications, and the laller has a beller survival Ihan does primary graft nonfuncllon. The difference In survival amonglhese groups Is stallstlcally sIgnificant. The quality of life for 164 of 173 survivors Is good to excellent; only nine children are currently experiencing medical problems. A perslsent problem In pediatriC transplanta· tlon Is the scarcity of smoll donors. (J PED1ATR 1987;111{6. part 2):1039-45)
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The clinical manifestations of chronic li\'er disease in the adult arc usually insidious and slow to progress. In contrast, the clinical features of cnd·stage li,er disease in children develop over a short time: 2nd are followed by devastating results. A t)pical example is tht patient with cirrhosis secondary to biliary atrcsia. In these paticnts, ja und ice, hypersplenism. and portal h) p<:rlension quickly devclop. in addition to the c<Jmplications of m~lab,orplion 5uch as diarrhea. growth retardation, and bone fractures.
was introduced into clinical practice in 1980. 1 The immediate impact of c)'closporine on sur.·ival ..... as so remarkable that in a fe .... yeaTS there has been a proliferation of new transpbnt ccnters all mer the .... orld. \10reover, the indications for hepatic replacement arc constantl) op3nding to beneflt more patients "'ho other .... isc w(luld incvitably die of hepatic failure (unpubli~hed data).
Three yca rs ago, ort hotopic liver tr a n~pla nta tion left the realm of c:r.rcrimental surgcry and became an accepted mode of therapy for patients .... ith irrevcrsible liver dis· easel The first human liver transplant .... as performed in 8 child 23 years ago, but progress was slow until c)'closporine Suprvrtrd by Rtsrarch Grants from the Vtttrans A<!ministration and b) Project Grant At.,1·29961 from the ~Jtio~Jllnstitutes of Health. We reporl the results in the first 250 pediatric paticnts "'ho receivcd liver transplants during the e)clo~porine era. Tmmuno~llprr('\~ion. Patients used to receive a dose of c)closporine orally a fe ..... hours before surgery, but this practice has been abJndoned. At pre~ent. cyclo'porine is begun during the operation at a dose of 2 mg/kg intravenously. The s:Jme do~e is repeated paSloperatildy elery 8 hours until olal feedings arc resumed. Oral C)closl"1rine is then begun at a dose of \7.5 mg/kg/d, divided in two doses. Intran:nously administered c)c1o~pvrine is subsequentl) reduce~ if adequate In'els are maintained b) the oral route. s Cyclosporine dosage is adjusted according to the concentration of the drug in whole blood as determined by high-pressure liquid chroamtography or by radioimmunoassay. RIA is used more frequently' in our practice. The dosage is also adjuqed based on symptoms and renal function. because the toxicity of the drug docs not al . . . . . ays correlate with the blood level. Steroids arc also started during the operation. A dose of 500 mg prednisolone: is givcn intral'enously soon after the allograft liver is revascularized. If the: patient'S clinical condition is relatilel), good, a S·da)' course of prednisolone is gilen. beginning . . . . . ith 100 mg the first day poqopcratilely, and tapering b)' 20 mg daily and cnding v.ith a mJintcnance do~c of 10 mg daily. further reductions of the steroid doses arc made on an indil'idual basis. In the presence of rejection, patients are: given h)drocortisone: intravenously. If no rc~pvnse is ob~ened, the: 5·day course of steroids is repeated.' Addi· tional adjulant therapy h:ls con,isted of pol)clonal anti· lymphocyte globulin in the: heginning of the ~eries and monoclonal antibody (OKT t 3 Orlhoclone:, Ortho Pharmaceutical Corporation, Raritan, N.J.) recently. The: most common indication for OKT t 3 therap)' has been steroid· resistant rejection.')n a fe ..... patients "ith btent rejection, 
METHODS

RESULTS
Indicalions for li\er Iransplanlalion. The: indications for hepatic replacement are: shown in Fig. I . There were I IS male: and 135 female palienls, with mean age 5.9 ± 4.92 (SO) years (range 4 months to 18 years). Almost all patients had ad\'2nced li\'er disease, except for an occasional patient who had received a transplant for hepatic malignancy and had li'cr function that \las normal or close to normal.
Biliary a(rfSia. The biliary atretic s)ndromc was by far the most common indication for liver tramplantation. In this group, the majority (84<;;) of patients had e:\trahepatic biliary atresia, and the rest had biliary h)J"-1plasia, which in some cases was part of Alagillc s)ndrome, Almoq all of the patients with bili.H) atresia had undergone a biliary drainage procedure (K2sai), and in sc\eral p3tients the hepatectomy was difficult because of adhesions formed after many prC\ious llbdomir.al operations,
The domin?nt clinical fe:lturc:s in patients \Ioith extrahepatic atresia are shown in Table I and are comp:ued with those in other !i\er tramplant recirients who \Ioere operated on because of diagnoses other than extrahepatic atresia. The incidence of \ariccaJ bleeding and a~cites \10 as similar in the,e t\\O groups of patients; ho\\C\er, cholangitis was a significant problem in pJtients with e\trahcp.1tic biliary atresia and was the cause of numerous ho'pitali73tions. Inborn urors. Inborn errors of metabolism were the second most common indication for hepatic transplantation; Crl·antitrypin deficient) \10 as the most common diagnosis in this group. T\Ioent)'·nine of the 2~O pediatric patients under\llcnt hepatic tramplantation because of ol,antitrypsin deficiency. The phenotype was ZZ in 22 patients, MZ in t\\O, SZ in two, and was unknown in three patients. The diagnosis of OJ-antitrypsin deficienc), was made between 1 month and 6 years, with initial symptoms of jaundice in 23 patients, ascites in three patients, and gastrointestinal hemorrhage in three patients. By the lime of trampl:Jntation, 17 (58.6o/c) of 29 patients "ith Cl Iantitr)psin deficiency h~d experienced "ariceal hemorrhare, and the grcat m:ljority had ascites (Table II) one, and thrombosis of the \'Cna ca\'a and portal vein in one patient. Of these siJ., three ~ith hepatic artery thrombosis died after retransplantation. Five of the 29 patients ~ith QI'antitr)psin deficiency died. Of the 24 sun'i\'ors, three patients have slightly abnormal liver function secondar)' to chronic rejection, and may eventually require retramplantation. Another patient has immunosuppression·induced I) mphoproliferati\'e dis· ease, Another patient v.ho had QI·antitr)psin deficiency and biliary atresia has an ind\<dling percutaneous biliary catheter because of an ischemic obstruction of the bile ducts, This patient had thrombosis of the hepatic arlery poqopcrati\ely. T .... ent) of the 24 allend school; the other four are not of school age, but arc gro",ing v.ell.
Other metabolic disorders treated .... ith hepatic trans· plantation were t) rminrmia, Wilson di~ease, gl)cogen storage dj~C'ase, and familial h) pcrcholc>tcrolemia.
Less frequent indications .... cre con£enital heratic fibrosis, familial <:holestasis, p0;tnecrotic cirrhosis, secondary biliar)' cirrhosis, ncon3t31 hepatitis, and malignancy.
Suni\sl. The o\erall actu:;rial survi\'al in rediatric p;'ltients is 69.29C al 5 years, .... hich is significantl) beller when compared ~ith a hi~torical group giHn azathioprine (23%). Comparcd .... ith that in adults, the sun'i\'al is identical up to 2 )ears; the difference in adult sun'i\'31 after 2 years is not statistically significant (Fig, 2) , Ovcrthe last 2 years there has been an increase in the number of hepatic tramrlants in infants. The actu"rial sun'ival in these small children ~as not statisticall) different from that in older patients (Fig. 3) ; hov.ner, the rostorerati\e course in many of these infants was mailed by comrli~alions."
Influencr of diagnosis on sunh.1. There is very little difference in survival according to the diagnostic indica· tions for hepatic replacement (Fig. 4) , Most of the deaths occur within the first 6 months after transplantation, and the allrition is minimal after I year. The S')'ear actuarial survival is 77.8~ for patients with postnecrotic cirrhosis (n -27), 79.2~ for patients with inborn errors of the metabolism (n .. 53), and 66.lo/c for patients with biliary atretic s)ndrome (n .. 127).
The principal causes of death in 61 consecuti\'c children who died at the Uni\ersity of Piltsburgh, in decrcasing order of frequency, .... ere infection (22 patients, 36%) hepatic necrosis (12 patients. 20O/C), central nen'ous system complications (eight patients, 139C), and intraabdominal hemorrhage (sc\en patients, 11'k), T .... clve other patients died of misccllaneous cau~es such as respiratory distress syndrome, m)ocardial infarction, I) mrhoproliferati\'c dis· case, recurrent hepatoma, and multis)qem organ failure (Table III) (43.3<;;). and primary graft nonfunction in nine (13.4~) (Fig_ 5). Technical complications arc seen more frequently in children than in adults; hepatic artery thrombosis accounts for nearly all technical problems requiring ret ra nsplantation. The difference in sun'ival after retransplantation for the foregoing three indications is highly significant. Patients requiring a second transplant bccau~e: of primary graft nonfunction had the poorest survi\al (approximately 10% at I year), but actuarial sun'ival increased to 48'h at 4 years ",hen the indication was a technical complication. and to 79C;{ at 4 years when the reason for retransplantation was rejection.
Qualit) of life. Of the: 173 suni\ors, only nine pJtients are currently experiencing major medical probkms. Two of these pJtients ha\'e biliary strictures secondary to thrombosis of the hepatic artery, and con<.equent mild hepJtic dysfunction. Two other p~tients. "ho had trans· plants before I ycar of age. have ind\\elling biliary catheters because of necrosis of the major bik ducts after thrombosis of the hepatic artery, Unlikc the previous two p.lticnts, the hepatic function in thC<.e t\\O pJticnts is occllen\. Three ratient~ have ongoing chronic rcje(tion and \\ ill require retraosplantation. One p.1ticnt "ho under· ",cnt simultaneous liver and kidney tran'plantation bCC:1U~C of c)'qino~is undergoes hCl11odial)sis for chronic renal failure; he has normal li\er function. ahhough he 5tiJ1 has residual tumor; his condition is stable, and immuno,uppression therapy has been stopped entirely. The remaining patients live normal lives and have nearnormal gro"th and development. Eight (28'/() of 29 patients crossed percentiles in nn upward direction and "'ere above the: 5th percentile:, Thirteen patients "'ere belo\\ the 5th percentile before and after ~urgcr)'; of the~e, 10 h3\'e normal po"th \elocit)', Only fOllr (14':;) p:lticnls had a reduction in gro\\th to belo" the 5th percentile. Four (14o/c) other pJtients "'ho "t:re nornnlly gro\\n before hepatic replacement continued to grow normally after ~urger)'. Thirteen of these 29 pJticnts h3d biliary atresia.~b combination of C)'clo~rorine and prednisone, in contrast to those given a combination of a7athioprine and prednisone in earlier series. 2 When liver tran;plantation was first performed in the 1960s, a frequent indication for hepatic replacement was malignancy, because those patients had no chance for survival otherwise. Howe\·er. many other patients" ho would benefit from Ih'er transplantation were not consid· ered because of the opcrimcntal nature of the operation. Based on the much improved rcsults .... ith c)closporine. liver transplantation became an acccpted therapy for patients "jth adl'aneed hepatic di~ease in the 19f.0s.1.' Age limitations are not as relclant as they "ere before e)closporine (unpubli~hed data). t-.:oncthc1ess, a significant problem in pediatric liler transplantation continues to be the scarcity of small pcdi;lIric donors.
DISCUSSION
The arpropriate: time for tran~planlation i~ .... hen the palient begins to ~holl signs of hepatic dccompcn'3tion. In children, 5ubtlc signs arc fatigue. failure to grow, and deereJscd activity bel. liver transrbntation should not be d.:1J)cd until manifeQ;llions of end~stage lilcr di~ease de\ elor. such as \arieeal bleeding or encerhalopathy. Althl)ugh it has becn difficult to predict II hich rJtients "ill do lIell 2fter transplantation,' it is logical to think that paticnt~" ho still hal'c some resen'c would fare better after hepatic transrbntation than patients \\ith terminJI qages of the dise3se such as hcp:llorenal S} ndrome:. rrom the \iel\point of stat is Ii cal significance. the under· I) ing disc3sc docs not influence the (lutcomc. Cirrhosis ~ccond:lTy to biliary 3tresiil, hep:lIitis, 1l"3ntitr)r,in defi· ciency, and Wilson disease is a c1ear·cut indication for hepatic replacement. T)Tosinemia, on the other hand, is an inborn error of mc:taboli~m associated with a high inei· dence of hepatoma. These patients should undergo hepatic replacement before malignancy occurs. Likewise, other metabolic disorders that hal'e their origin in the li\er, such as gl}eogen storage disease. hemochromatosis. and possibly hemophilia. are treated more frequently" ith liver transplantation. The presence of mJlignaney is not an ab~olute contraindication, although the risk of recurrence exists. In a previous invcstigation, patients" ho had inci· dent~1 neoplasms in the liler and underllenl trJn~pbnta· tion for other rea~ons h;l\e sho"n no clidcnce of recur· rence thus far. ' Most of the deaths in pediatric li\er transpl;;ntation occur within the first 6 months. Infe.:tions arc the most common cause of death. and the l)PC of infection laries according to the time of omct after tran'pbntJtion and the precipitating cau~e. Early infections arc USUJII) bacterial or fungal and arc precipitated by complic~tions related to the operation, such as arh:rial thTllIl1b-.."is, bile k.1h. or intestinal perforations. Viral complications arc ~een late, and u~ually fol1o\\ unlli~e therapy for rejection.
The majority of the children will ha\'e an alm05t normal life c\ecpt for the need of medication. This is a ~r1Iall price, con~idcring that dLath \\(luld be their fate 1\ ithout liver tran~plantation. The m:ljorit) of th<"<,e children gro\\ nor· m:llly after hepatic repbcemcnt and arc able to attend ~(hool and pJrticipJte in daily aClilities.
Patients "ith primMY graft nonfunction dl,teriorate rapidly, and retransplantation is urlent. Thrombosis of the hepatic .rtery may lead to regional necrosis of the liver and abscess formatIOn. Althoul!h a few patients have survived without arterial supply, these patients should also underl!o retran~plantation immediatel)·.'~ Retransplantatlon because of rejection is associated with the best survival, probably because these patients are usually free of infection and arc in better condition than those with primary graft nonfunction or thrombosis of the hepatic artery. Retransplantation has played an important role in improve ing survival. "
We conclude that liver transplantation is the treatment of choice for several conditions leading to end-stage liver disease. The most important problem in pediatric Jiver transplantation is the una\'ailability of small pediatric donors.
